R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma.
Diana Al-SarayfiFrederik O MeeuwesMüjde DurmazDjamila E IssaRolf E BrouwerAart BeekerAnna van RhenenPim G N J MutsaersLara H BöhmerMarjolein W M van der PoelLiane Te BoomeTom van MeertenMartine E D ChamuleauJosée M ZijlstraMirian BrinkMarcel NijlandPublished in: Blood cancer journal (2022)